ClinVar Miner

Submissions for variant NM_000266.4(NDP):c.269G>A (p.Arg90His)

gnomAD frequency: 0.00003  dbSNP: rs104894867
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001306511 SCV001495886 uncertain significance not provided 2023-04-22 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 90 of the NDP protein (p.Arg90His). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant disrupts the p.Arg90 amino acid residue in NDP. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 14635119). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on NDP protein function. ClinVar contains an entry for this variant (Variation ID: 812352). This missense change has been observed in individual(s) with Norrie disease (PMID: 31456290). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database.
Department of Otolaryngology – Head & Neck Surgery, Cochlear Implant Center RCV001375287 SCV001571861 likely pathogenic Hearing impairment 2021-04-12 criteria provided, single submitter clinical testing PM2_Moderate, PM5_Moderate, PP3_Supporting
Laboratoire Génétique Moléculaire, CHRU TOURS RCV001306511 SCV001760757 benign not provided 2019-06-04 criteria provided, single submitter clinical testing
GeneDx RCV001306511 SCV002504561 likely benign not provided 2019-10-31 criteria provided, single submitter clinical testing See Variant Classification Assertion Criteria.
Sharon lab, Hadassah-Hebrew University Medical Center RCV001003091 SCV001161152 likely pathogenic Atrophia bulborum hereditaria 2019-06-23 no assertion criteria provided research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.